Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the treatment is complex, and patients may have many complicated supportive care issues. The NCCN Guidelines for Pediatric Aggressive Mature B-Cell Lymphomas provide guidance regarding pathology and diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Journal of the National Comprehensive Cancer Network : JNCCN - 18(2020), 8 vom: 25. Aug., Seite 1105-1123 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Davies, Kimberly [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 04.11.2021 Date Revised 04.11.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.6004/jnccn.2020.0036 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313311919 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313311919 | ||
| 003 | DE-627 | ||
| 005 | 20231225150314.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.6004/jnccn.2020.0036 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1044.xml |
| 035 | |a (DE-627)NLM313311919 | ||
| 035 | |a (NLM)32755986 | ||
| 035 | |a (PII)jnccnGLS1808 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Davies, Kimberly |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.11.2021 | ||
| 500 | |a Date Revised 04.11.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the treatment is complex, and patients may have many complicated supportive care issues. The NCCN Guidelines for Pediatric Aggressive Mature B-Cell Lymphomas provide guidance regarding pathology and diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 700 | 1 | |a Barth, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Armenian, Saro |e verfasserin |4 aut | |
| 700 | 1 | |a Audino, Anthony N |e verfasserin |4 aut | |
| 700 | 1 | |a Barnette, Phillip |e verfasserin |4 aut | |
| 700 | 1 | |a Cuglievan, Branko |e verfasserin |4 aut | |
| 700 | 1 | |a Ding, Hilda |e verfasserin |4 aut | |
| 700 | 1 | |a Ford, James B |e verfasserin |4 aut | |
| 700 | 1 | |a Galardy, Paul J |e verfasserin |4 aut | |
| 700 | 1 | |a Gardner, Rebecca |e verfasserin |4 aut | |
| 700 | 1 | |a Hanna, Rabi |e verfasserin |4 aut | |
| 700 | 1 | |a Hayashi, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Kovach, Alexandra E |e verfasserin |4 aut | |
| 700 | 1 | |a Machnitz, Andrea Judit |e verfasserin |4 aut | |
| 700 | 1 | |a Maloney, Kelly W |e verfasserin |4 aut | |
| 700 | 1 | |a Marks, Lianna |e verfasserin |4 aut | |
| 700 | 1 | |a Page, Kristin |e verfasserin |4 aut | |
| 700 | 1 | |a Reilly, Anne F |e verfasserin |4 aut | |
| 700 | 1 | |a Weinstein, Joanna L |e verfasserin |4 aut | |
| 700 | 1 | |a Xavier, Ana C |e verfasserin |4 aut | |
| 700 | 1 | |a McMillian, Nicole R |e verfasserin |4 aut | |
| 700 | 1 | |a Freedman-Cass, Deborah A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the National Comprehensive Cancer Network : JNCCN |d 2003 |g 18(2020), 8 vom: 25. Aug., Seite 1105-1123 |w (DE-627)NLM156397676 |x 1540-1413 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2020 |g number:8 |g day:25 |g month:08 |g pages:1105-1123 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.6004/jnccn.2020.0036 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2020 |e 8 |b 25 |c 08 |h 1105-1123 | ||